The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: A double-blind randomized-controlled trial

European Journal of Vascular and Endovascular Surgery

Volumn 25, Issue 6, 2003, Pages 513-518

  Abidia, A ^a   Laden, G ^b   Kuhan, G ^a   Johnson, B F ^a   Wilkinson, A R ^a   Renwick, P M ^a   Masson, E A ^a   McCollum, P T ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

^b BUPA Hospitals   (United Kingdom)

Author keywords

Diabetes mellitus; Hyperbaric oxygenation; Peripheral arterial diseases; Randomised controlled trial; Wound healing

Indexed keywords

ANTIBIOTIC AGENT; OXYGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG COST; EPITHELIZATION; FEMALE; HEALTH CARE COST; HIGH RISK PATIENT; HUMAN; HYPERBARIC OXYGEN; LEG ISCHEMIA; LEG ULCER; MALE; OXYGEN TENSION; OXYGEN THERAPY; PLASTIC SURGERY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WOUND HEALING; WOUND INFECTION;

EID: 0038510887     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejvs.2002.1911     Document Type: Article

References (32)

1. KUMAR S, ASHE HA, PARNELL LN et al. The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population-based study. Diabet Med 1994; 11: 480-484.
2. NEIL HA, THOMPSON AV, THOROGOOD M, FOWLER GH, MANN JI. Diabetes in the elderly: the Oxford Community Diabetes Study. Diabet Med 1989; 6: 608-613.
3. RAMSEY SD, NEWTON K, BLOUGH D et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabet Care 1999; 22: 382-387.
4. APELQVIST J, LARSSON J, AGARDH CD. Long-term prognosis for diabetic patients with foot ulcers. J Intern Med 1993; 233: 485-491.
5. PECORARO RE, REIBER GE, BURGESS EM. Pathways to diabetic limb amputation. Basis for prevention. Diabet Care 1990; 13: 513-521.
6. MCNEELY MJ, BOYKO EJ, AHRONI JH et al. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks? Diabet Care 1995; 18: 216-219.
7. WALTERS DP, GATLINC W, MULLEE MA, HILL RD. The distribution and severity of diabetic foot disease: a community study with comparison to a non-diabetic group. Diabet Med 1992; 9: 354-358.
8. EDMONDS ME, BLUNDELL MP, MORRIS ME, THOMAS EM, COTTON LT, WATKINS PJ. Improved survival of the diabetic foot: the role of a specialized foot clinic. Q J Med 1986; 60: 763-771.
9. SHEFFIELD PJ. Measuring tissue oxygen tension: a review. Undersea Hyperb Med 1998; 25: 179-188.
10. NIINIKOSKI J, GRISLIS G, HUNT TK. Respiratory gas tensions and collagen in infected wounds. Ann Surg 1972; 175: 588-593.
11. HUNT TK, PAI MP. The effect of varying ambient oxygen tensions on wound metabolism and collagen synthesis. Surg Gynecol Obstet 1972; 135: 561-567.
12. KNIGHTON DR, HALLIDAY B, HUNT TK. Oxygen as an antibiotic. A comparison of the effects of inspired oxygen concentration and antibiotic administration on in vivo bacterial clearance. Arch Surg 1986; 121: 191-195.
13. KNIGHTON DR, SILVER IA, HUNT TK. Regulation of wound-healing angiogenesis-effect of oxygen gradients and inspired oxygen concentration. Surgery 1981; 90: 262-270.
14. TIBBLES PM, EDELSBERG JS. Hyperbaric-oxygen therapy. N Engl J Med 1996; 334: 1642-1648.
15. LEACH RM, REES PJ, WILMSHURST P. Hyperbaric oxygen therapy. BMJ 1998; 317: 1140-1143.
16. WUNDERLICH RP, PETERS EJ, LAVERY LA. Systemic hyperbaric oxygen therapy: lower-extremity wound healing and the diabetic foot. Diabet Care 2000; 23: 1551-1555.
17. HAMMARLUND C, SUNDBERG T. Hyperbaric oxygen reduced size of chronic leg ulcers: a randomized double-blind study. Plast Reconstr Surg 1994; 93: 829-833.
18. LOGERFO FW, COFFMAN JD. Current concepts. Vascular and microvascular disease of the foot in diabetes. Implications for foot care. N Engl J Med 1984; 311: 1615-1619.
19. JAAP AJ, HAMMERSLEY MS, SHORE AC, TOOKE JE. Reduced microvascular hyperaemia in subjects at risk of developing type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1994; 37: 214-216.
20. FLYNN MD, TOOKE JE. Aetiology of diabetic foot ulceration: a role for the microcirculation? Diabet Med 1992; 9: 320-329.
21. BOULTON AJ. The diabetic foot. Med Clin North Am 1988; 72: 1513-1530.
22. MORAIN WD, COLEN LB. Wound healing in diabetes mellitus. Clin Plast Surg 1990; 17: 493-501.
23. SIDDIQUI A, DAVIDSON JD, MUSTOE TA. Ischemic tissue oxygen capacitance after hyperbaric oxygen therapy: a new physiologic concept. Plast Reconstr Surg 1997; 99: 148-155.
24. ABIDIA A, KUHAN G, BAHIA H, CHETTER I, MCCOLLUM PT. Microvascular reflexes are influenced by oxygen in diabetic patients with peripheral arterial disease. Br J Surg 2001; 88: 749.
25. Consensus Development Conference on Diabetic Foot Wound Care: 7-8 April 1999, Boston, Massachusetts. American Diabetes Association. Diabet Care 1999; 22: 1354-1360.
26. MASON J, O'KEEFFE C, HUTCHINSON A, MCINTOSH A, YOUNG R, BOOTH A. A systematic review of foot ulcer in patients with Type 2 diabetes mellitus. II: treatment. Diabet Med 1999; 16: 889-909.
27. OYIBO SO, JUDE EB, TARAWNEH I et al. The effects of ulcer size and site, patient's age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers. Diabet Med 2001; 18: 133-138.
28. FAGLIA E, FAVALES F, ALDEGHI A et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabet Care 1996; 19: 1338-1343.
29. KALANI M, JORNESKOG G, NADERI N, LIND F, BRISMAR K. Hyperbaric oxygen therapy in treatment of diabetic foot ulcers. Lon-term follow-up. J Diab Complications 2002; 16: 153-158.
30. BARONI G, PORRO T, FAGLIA E et al. Hyperbaric oxygen in diabetic gangrene treatment. Diabet Care 1987; 10: 81-86.
31. ZAMBONI WA, WONG HP, STEPHENSON LL, PFEIFER MA. Evaluation of hyperbaric oxygen for diabetic wounds: a prospective study. Undersea Hyperb Med 1997; 24: 175-179.
32. BAKKER DJ. Hyperbaric oxygen therapy and the diabetic foot. Diabet Metab Res Rev 2000; 16: S55-S58.